Please provide your email address to receive an email when new articles are posted on . Increased use of fecal immunochemical testing correlated with more colorectal cancer screenings and early-stage ...

Please provide your email address to receive an email when new articles are posted on . Noninvasive fecal immunochemical testing is an effective alternative to colonoscopy and stool blood-based ...

The updated national colorectal cancer screening guidelines that recommend screening begin at age 45—rather than 50—can benefit younger adults, a new Kaiser Permanente study found. Lowering the fecal ...

Targeted interventions by patient characteristics to improve fecal immunochemical test completion could reduce disparities in colorectal cancer screening and improve overall compliance with screening ...

Fecal immunochemical testing, which tests for human blood in a patient’s stool, is now available as a take-home test from Life Line Screening, according to a company news release. The test requires no ...

About The Study: In this nested case-control study, completing fecal immunochemical test was associated with a lower risk of overall death from colorectal cancer, particularly in the left colon, and ...

A recent study published in the Annals of Internal Medicine examined the accuracy of fecal immunochemical tests, an at-home stool test, as colon cancer screening tool, according to a Medscape report.

Three-quarters of people prefer to do a fecal immunochemical test (FIT) rather than a colonoscopy for their regular colorectal cancer screening, according to a new Cedars-Sinai study. Unlike ...

In this study, the performance characteristics of the immunochemical test were superior to those of the Hemoccult II guaiac-based test. Note, however, that Hemoccult II is less sensitive than the ...

The fecal immunochemical test (FIT) is highly effective for annual colorectal cancer screening programs for average-risk patients, according to results of a study published online January 26 in the ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech ...

Commercially available noninvasive screening tests for colorectal cancer - a fecal immunochemical test (FIT) and the multi-target stool DNAtest (mt-sDNA; or Cologuard ®) - are equally effective for ...